Newgen Q2: PAT +6% YoY, margin back in guided band, revenue growth slows to ~5%
PAT +6.29% YoY · revenue +5.35% · margins expanding · beat vs street
₹422.24 Cr
+5.35% YoY
₹86.88 Cr
+6.29% YoY
20.03%
+0.3pp YoY
₹6.16
Newgen's consolidated Q2 FY27 (quarter ended 30 September 2026) print is a beat-and-recover quarter rather than an unambiguous acceleration: revenue from operations came in at ₹422.24 Cr, up 5.4% YoY from ₹400.79 Cr and a sharp 18.4% QoQ from ₹356.68 Cr, while consolidated PAT rose 6.3% YoY to ₹86.88 Cr (from ₹81.74 Cr) and 38.3% QoQ (from ₹62.82 Cr). EPS (basic) was ₹6.16 versus ₹5.82 a year ago and ₹4.44 last quarter. No exceptional items sit in either the current or year-ago quarter, so these are clean, unadjusted comparisons.
Q2 FY-2027 vs prior quarters
The headline QoQ jump is largely mean-reversion from an unusually soft Q1, when the company itself flagged a "volume surge" tied to market factors (disclosed 31 August 2026) that compressed Q1 margins to an OPM of 15.7%/NPM of 16.0%. This quarter's OPM recovered to ~25.8% and NPM to 20.0%, both back in line with — and OPM modestly above — management's guided 23-25% full-year EBITDA margin band, and roughly flat-to-up against the year-ago quarter's 25.6%/19.7%. The margin bridge runs through employee and other operating costs relative to revenue; the filing does not break out annuity-vs-other revenue mix, so that driver can't be confirmed from these figures alone.
The stock went into the print at ₹462, down 6.8% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters.
Management expressed confidence in accelerating growth for the remainder of the fiscal year, driven by strong annuity and subscription revenue streams. While specific full-year revenue guidance wasn't provided due to company size, a double-digit growth rate is expected, building on Q1 performance. Profitability is targ
— This quarter: missed
Against our pre-result preview — which pencilled in revenue of ~₹362 Cr, PAT of ₹62-65 Cr and an EBITDA margin of ~21-22% — the actual print is a clear beat on all three (revenue +16.6%, PAT 34-40% above the range, margin ~4pp above the top end); the Street's 5/0/2 buy-sell-hold split with recently trimmed targets (ICICI Securities BUY at ₹580; others cutting fair value toward ₹615) looks conservative in hindsight on this number. Geographically, EMEA (₹148.39 Cr) and USA (₹111.18 Cr) remain the largest consolidated revenue contributors, with India at ₹102.99 Cr. Standalone growth is notably softer than consolidated — standalone revenue rose just 0.9% YoY and PAT 3.7% YoY versus 5.4%/6.3% consolidated — indicating overseas subsidiaries did the heavier lifting this quarter. The Board also approved, same day, a scheme to amalgamate wholly-owned subsidiary Newgen Computers Technologies into the parent (appointed date 1 April 2026) — a structural reorganisation with no P&L impact this quarter since the subsidiary was already consolidated.
W1
Whether Q3 YoY revenue growth re-accelerates toward management's double-digit full-year target (H1 FY27 YoY revenue was +8.0% against that bar).
W2
OPM sustainability within the guided 23-25% band after this quarter's ~25.8% print, following Q1's volume-surge-driven dip to 15.7%.
W3
Recognition timing on recent large deals (₹52.55 Cr US health-insurer, ₹17.14 Cr Qatar, £1.63M UK) flowing into reported revenue over the next 1-2 quarters.
Informational and educational content only. Not investment advice.